RE:RE:RE:RE:RE:RE:JAMA Cardiology StudyExactly, good call. If you're not invested in the company, or considering being invested, there is no reason to be here. Unless of course, you're being rewarded to spread doubt. Many companies valuations do not match their share price, this is not rocket science. You factor in "possibility and chance" and weigh it against "market conditions and sector comparables" and come up with market value. Right now you could make the argument vpt is worth $12 per share or $.12 per share, it's up to the individual investor to determine what they believe. G-Bomb wants you to only focus on the bottom and that is why he's a D-Bag.